| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Growth/differentiation factor 15|GDF-15|Macrophage inhibitory cytokine 1|MIC-1|NSAID-activated gene 1 protein|NAG-1|NSAID-regulated gene 1 protein|NRG-1|Placental TGF-beta|Placental bone morphogenetic protein|Prostate differentiation factor|GDF15|MIC1|PDF|PLAB|PTGFB |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human GDF15 (Growth Differentiation Factor 15) is a molecular target commonly studied in signal transduction, cardiovascular, and developmental biology research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of GDF15 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of GDF15 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
GDF15 (Growth Differentiation Factor 15) may also be referenced as Growth/differentiation factor 15, GDF-15, and Macrophage inhibitory cytokine 1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how GDF15 relates to vascular biology and endothelial function, cardiac remodeling and injury responses, thrombosis and hemostasis, and blood pressure regulation in signal transduction, cardiovascular, and developmental biology research.
- Interpreting shifts in GDF15 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
GDF15 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with signal transduction, cardiovascular, and developmental biology studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Circulating Growth Differentiation Factor 15 (GDF15) in Paediatric Disease: A Systematic Review
IF: 9.4 Journal: Journal of Cachexia, Sarcopenia and Muscle Author: Indiana University School of Medicine, Indianapolis, Indiana, USA. Cited Date: 2025-03-07
Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery.
IF: 4.1 Journal: Biomedical Journal Author: Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain. Cited Date: 2024-12-06
The upregulation of GDF15 is controlled epigenetically by oncogenic TCF19 signaling in human hepatocellular carcinoma
IF: 4.1 Journal: iScience Author: Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines Cited Date: 2025-09-12
Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children
IF: 3.418 Journal: Frontiers in Pediatrics Cited Date: 2022-05-06
Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function
IF: 3.3 Journal: European Review for Medical and Pharmacological Sciences Author: Department of Cardiovascular Medicine, Shaanxi Provincial People’s Hospital, Xi’an, China Cited Date: 2023-10-13
Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients
IF: 1.615 Journal: Indian Journal of Hematology and Blood Transfusion Cited Date: 2020-06-30
The Relationship of Hepcidin, Soluble Transferrin Receptor, Growth Differentiation Factor-15 And Anemia in Multipl Myeloma
IF: Journal: Konuralp Medical Journal Author: Department of Hematology, Department of Internal Medicine, Duzce Faculty of Medicine, Cited Date: 2023-11-10
Growth Differentiation Factor-15 as a Biomarker of Atrial Fibrillation Recurrence after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation and Obstructive Sleep Apnea
IF: Journal: Recipe Cited Date: 2022-11-03
CIRCULATING SERUM LEVELS OF GROWTH DIFFERENTIATION FACTOR-15 IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME
IF: Journal: Biological Markers in Fundamental and Clinical Medicine Cited Date: 2018-11-15
The Upregulation of Growth Differentiation Factor 15 is Controlled Epigenetically by Oncogenic RAN/TCF19 Signaling in Human Hepatocellular Carcinoma
IF: Journal: SSRN Author: Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre, Singapore 169610, Singapore Cited Date: 2025-03-28